Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-18-015342
Filing Date
2018-05-17
Accepted
2018-05-17 15:31:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 32003
  Complete submission text file 0000000000-18-015342.txt   45051
Mailing Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017
Business Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017 (813) 864-4523
SELLAS Life Sciences Group, Inc. (Filed for) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations